Skip to main content
Sascha Tuchman, MD, Hematology, Chapel Hill, NC

SaschaA.TuchmanMDMHS

Hematology • Chapel Hill, NC

Clinical Professor; Director of Multiple Myeloma and Amyloidosis Program; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Join to view full profile

Dr. Tuchman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tuchman's full profile

Already have an account?

  • Office

    101 Manning Dr
    Chapel Hill, NC 27514
    Phone+1 984-974-0000
    Fax+1 984-974-8612

Summary

  • Dr. Sascha Tuchman, MD, is a hematologist based in Chapel Hill, NC, specializing in multiple myeloma. He completed his residency and fellowship in Hematology and Medical Oncology at Duke University Hospital and currently serves as a Clinical Professor at UNC Health Care. Dr. Tuchman has an extensive background in clinical research, with numerous publications in noted journals and involvement in several clinical trials focused on plasma cell disorders and multiple myeloma. He received the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, Epic Systems Corporation in 2013.

Education & Training

  • Duke University School of Medicine
    Duke University School of MedicineMHS, Clinical Research Training Program, 2008 - 2016
  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2010
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2003 - 2006
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 2003

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2003 - 2025
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase 1b/2 Study of Selinexor, Carfilzomib, and Dexamethasone (SKd) in Relapsed/ Refractory Multiple Myeloma (RRMM)
    Sascha A Tuchman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...
    Sascha A Tuchman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment
    Sascha A Tuchman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • How COVID-19 Vaccines Were Made so Quickly Without Cutting Corners
    How COVID-19 Vaccines Were Made so Quickly Without Cutting CornersJune 29th, 2021

Professional Memberships

Dr. Sascha Tuchman, Dr. Sascha Tuchman, MD, Dr. S Tuchman, Dr. Sascha A. Tuchman